Mainz Biomed B.V.

NASDAQ: MYNZ · Real-Time Price · USD
1.76
0.07 (4.14%)
At close: Aug 15, 2025, 3:59 PM
1.69
-3.98%
After-hours: Aug 15, 2025, 05:30 PM EDT

Mainz Biomed B.V. Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
-10.63M -11.02M -5.18M -8.25M -13.78M -12.6M -11.43M -240.75K
Depreciation & Amortization
520.09K 496.95K 204.47K 171.02K 317.43K 62.37K 35.09K 34.84K
Stock-Based Compensation
108.05K 1.03M 818.99K 2.1M 4.14M 5.68M 6.43M 1.61M
Other Working Capital
-493K 450.66K -192.7K 1.9M -385.87K 332.08K -840.7K 24.45K
Other Non-Cash Items
1.4M 959.71K -712.85K 4.76K 1.7M 154.67K 2.66M 119.54K
Deferred Income Tax
n/a n/a -17.54K n/a n/a n/a -6.49M -1.74M
Change in Working Capital
-342.23K 393.98K 235.08K 1.78M -683.83K 246.44K -784.16K 11.98K
Operating Cash Flow
-8.95M -8.14M -4.66M -5.12M -8.31M -6.46M -3.09M -228.77K
Capital Expenditures
-134.29K -120.66K -261.81K -123.63K -406.04K -252.45K -12.13K -4.58K
Cash Acquisitions
32.78K n/a n/a n/a n/a n/a 1.22M n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
173.35K -300K -200K -500K n/a n/a 1.22M n/a
Investing Cash Flow
221.84K -420.66K -374.29K -123.63K -406.04K -252.45K 1.21M -4.58K
Debt Repayment
1.09M 2.04M -1.97M 4.39M n/a -45.69K n/a 217.03K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-810.52K 515.26K 934.87K n/a -148.23K 24.14M 10.39M n/a
Financial Cash Flow
14.05M 2.55M 3.47M 5.42M -148.23K 24.09M 10.39M 503K
Net Cash Flow
5.26M 977.76K -2.25M 52.88K -26.01M 26.01M 1.99M 243.59K
Free Cash Flow
-9.08M -8.27M -4.92M -5.24M -8.72M -6.71M -3.1M -233.35K